176 related articles for article (PubMed ID: 37600714)
1. Neuropilin 2 in osteoblasts regulates trabecular bone mass in male mice.
Verlinden L; Doms S; Janssens I; Meyer MB; Pike JW; Carmeliet G; Verstuyf A
Front Endocrinol (Lausanne); 2023; 14():1223021. PubMed ID: 37600714
[TBL] [Abstract][Full Text] [Related]
2. Nrp2 deficiency leads to trabecular bone loss and is accompanied by enhanced osteoclast and reduced osteoblast numbers.
Verlinden L; Kriebitzsch C; Beullens I; Tan BK; Carmeliet G; Verstuyf A
Bone; 2013 Aug; 55(2):465-75. PubMed ID: 23598046
[TBL] [Abstract][Full Text] [Related]
3. The Vitamin D Receptor in Osteoblast-Lineage Cells Is Essential for the Proresorptive Activity of 1α,25(OH)2D3 In Vivo.
Mori T; Horibe K; Koide M; Uehara S; Yamamoto Y; Kato S; Yasuda H; Takahashi N; Udagawa N; Nakamichi Y
Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32987399
[TBL] [Abstract][Full Text] [Related]
4. Lack of the Thyroid Hormone Transporter Mct8 in Osteoblast and Osteoclast Progenitors Increases Trabecular Bone in Male Mice.
Lademann F; Tsourdi E; Rijntjes E; Köhrle J; Hofbauer LC; Heuer H; Rauner M
Thyroid; 2020 Feb; 30(2):329-342. PubMed ID: 31910109
[No Abstract] [Full Text] [Related]
5. Semaphorin 3B is a 1,25-Dihydroxyvitamin D3-induced gene in osteoblasts that promotes osteoclastogenesis and induces osteopenia in mice.
Sutton AL; Zhang X; Dowd DR; Kharode YP; Komm BS; Macdonald PN
Mol Endocrinol; 2008 Jun; 22(6):1370-81. PubMed ID: 18356290
[TBL] [Abstract][Full Text] [Related]
6. Class 3 semaphorins are transcriptionally regulated by 1,25(OH)
Ryynänen J; Kriebitzsch C; Meyer MB; Janssens I; Pike JW; Verlinden L; Verstuyf A
J Steroid Biochem Mol Biol; 2017 Oct; 173():185-193. PubMed ID: 28189595
[TBL] [Abstract][Full Text] [Related]
7. VDR in Osteoblast-Lineage Cells Primarily Mediates Vitamin D Treatment-Induced Increase in Bone Mass by Suppressing Bone Resorption.
Nakamichi Y; Udagawa N; Horibe K; Mizoguchi T; Yamamoto Y; Nakamura T; Hosoya A; Kato S; Suda T; Takahashi N
J Bone Miner Res; 2017 Jun; 32(6):1297-1308. PubMed ID: 28177161
[TBL] [Abstract][Full Text] [Related]
8. Kruppel-like factor 4 attenuates osteoblast formation, function, and cross talk with osteoclasts.
Kim JH; Kim K; Youn BU; Lee J; Kim I; Shin HI; Akiyama H; Choi Y; Kim N
J Cell Biol; 2014 Mar; 204(6):1063-74. PubMed ID: 24616223
[TBL] [Abstract][Full Text] [Related]
9. Osteoblastic NF-κB pathway is involved in 1α, 25(OH)2D3-induced osteoclast-like cells formation in vitro.
Cong L; Zhang C; Tu G
Int J Clin Exp Pathol; 2015; 8(5):5988-96. PubMed ID: 26191332
[TBL] [Abstract][Full Text] [Related]
10. Skeletal resistance to 1,25-dihydroxyvitamin D3 in osteopetrotic rats.
Safadi FF; Hermey DC; Popoff SN; Seifert MF
Endocrine; 1999 Dec; 11(3):309-19. PubMed ID: 10786828
[TBL] [Abstract][Full Text] [Related]
11. New 19-nor-(20S)-1alpha,25-dihydroxyvitamin D3 analogs strongly stimulate osteoclast formation both in vivo and in vitro.
Sato M; Nakamichi Y; Nakamura M; Sato N; Ninomiya T; Muto A; Nakamura H; Ozawa H; Iwasaki Y; Kobayashi E; Shimizu M; DeLuca HF; Takahashi N; Udagawa N
Bone; 2007 Feb; 40(2):293-304. PubMed ID: 17070129
[TBL] [Abstract][Full Text] [Related]
12. Deletion of the Distal Tnfsf11 RL-D2 Enhancer That Contributes to PTH-Mediated RANKL Expression in Osteoblast Lineage Cells Results in a High Bone Mass Phenotype in Mice.
Onal M; St John HC; Danielson AL; Pike JW
J Bone Miner Res; 2016 Feb; 31(2):416-29. PubMed ID: 26332516
[TBL] [Abstract][Full Text] [Related]
13. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
14. 1,25-Dihydroxyvitamin D3 induces the expression of vascular endothelial growth factor in osteoblastic cells.
Schlaeppi JM; Gutzwiller S; Finkenzeller G; Fournier B
Endocr Res; 1997 Aug; 23(3):213-29. PubMed ID: 9378108
[TBL] [Abstract][Full Text] [Related]
15. Short-term treatment of rats with high dose 1,25-dihydroxyvitamin D3 stimulates bone formation and increases the number of osteoblast precursor cells in bone marrow.
Erben RG; Scutt AM; Miao D; Kollenkirchen U; Haberey M
Endocrinology; 1997 Nov; 138(11):4629-35. PubMed ID: 9348188
[TBL] [Abstract][Full Text] [Related]
16. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of inhibitory action of eldecalcitol, an active vitamin D analog, on bone resorption in vivo.
Takahashi N
J Steroid Biochem Mol Biol; 2013 Jul; 136():171-4. PubMed ID: 23220095
[TBL] [Abstract][Full Text] [Related]
18. High dose 1,25(OH)2D3 inhibits osteoblast mineralization in vitro.
Yamaguchi M; Weitzmann MN
Int J Mol Med; 2012 May; 29(5):934-8. PubMed ID: 22307202
[TBL] [Abstract][Full Text] [Related]
19.
Moriishi T; Kawai Y; Fukuyama R; Matsuo Y; He YW; Akiyama H; Asahina I; Komori T
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139148
[TBL] [Abstract][Full Text] [Related]
20. Constitutive expression of osteoclast-stimulating activity by normal clonal osteoblast-like cells: effects of parathyroid hormone and 1,25-dihydroxyvitamin D3.
Collin P; Guenther HL; Fleisch H
Endocrinology; 1992 Sep; 131(3):1181-7. PubMed ID: 1505460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
